Extrahepatic bile duct cancer, a rare and aggressive malignancy, arises from the bile ducts outside the liver. It presents challenges in diagnosis and treatment due to its often asymptomatic nature until advanced stages. Research efforts in understanding its pathogenesis and identifying biomarkers for early detection are crucial. Advances in imaging modalities and molecular profiling offer promising avenues for diagnosis and personalized treatment strategies. Additionally, exploring novel therapeutic targets, such as immunotherapy and targeted therapy, holds potential for improving outcomes in this challenging disease. Collaborative interdisciplinary research endeavors are essential to unravel the complexities of extrahepatic bile duct cancer and develop effective interventions to enhance patient prognosis and quality of life.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States